Evaluation of a new automated, enzymatic inulin assay using d-fructose dehydrogenase

被引:15
作者
Kimata, Shinsuke [1 ]
Mizuguchi, Katsuhiko [2 ]
Hattori, Shizuo [2 ]
Teshima, Shinichi [2 ]
Orita, Yoshimasa [3 ]
机构
[1] Toyobo Co Ltd, Tsuruga Inst Biotechnol, Fukui 9140047, Japan
[2] Toyobo Co Ltd, Diagnost Syst Dept, Kita Ku, Osaka 5308230, Japan
[3] Osaka Jikei Res Ctr, Yodogawa Ku, Osaka 5320003, Japan
关键词
Glomerular filtration rate; Inulin clearance; Enzymatic method; Anthrone method;
D O I
10.1007/s10157-009-0174-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Inulin clearance (Cin) is widely considered to be a gold-standard assessment of glomerular filtration rate (GFR). Although inulin concentrations are commonly determined by the anthrone method, this method has several disadvantages, including a hazardous heating procedure using a strong acid, as well as a nonspecific reaction and being influenced by other saccharides such as glucose. Here, we report the development of a new automated, enzymatic inulin assay. This method uses d-fructose dehydrogenase (EC1.1.99.11), which does not require NAD or NADP as the electron acceptor, and utilizes oxygen transfer from hydrogen peroxide to an electron acceptor in a sensitive chromophoric system. This method allows rapid and accurate determination of inulin concentrations, and takes only 15 min on automated analyzers. We evaluated this new assay and compared it with the anthrone method. The detection limit value and linearity of the new method were 5 mg/l and up to 300 mg/l, respectively. The within-run precision coefficient of variations (CVs) for serum and for urine were 2.05 +/- A 0.79% (mean +/- A SEM; n = 3) and 0.92 +/- A 0.24%, respectively, and the between-run precision CVs for serum and for urine were 1.91 +/- A 0.72% and 1.86 +/- A 0.17%, respectively. No influence of glucose was observed with the new method, while a positive influence of 38.7% was observed with the anthrone method. However, neither method was influenced by fructose (3.0 mg/l in serum or 30 mg/l in urine). The analytical recovery rates of inulin were 97.8 +/- A 0.7% (mean +/- A SEM; n = 6) in serum and 99.0 +/- A 0.4% in urine using the enzymatic method. We compared results for the enzymatic method and the anthrone method using 46 serum samples and 46 urine samples. Bland-Altman plots showed no significant difference between the two methods for the serum samples. However, inulin recovery in the urine samples measured by the enzymatic method was about 5% higher than that obtained by the anthrone method. The new enzymatic assay offers a more convenient and more accurate measurement of inulin and may be suitable for routine procedures by automated analyzers in clinical laboratories.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 10 条
[1]   D-FRUCTOSE DEHYDROGENASE OF GLUCONOBACTER-INDUSTRIUS - PURIFICATION, CHARACTERIZATION, AND APPLICATION TO ENZYMATIC MICRO-DETERMINATION OF D-FRUCTOSE [J].
AMEYAMA, M ;
SHINAGAWA, E ;
MATSUSHITA, K ;
ADACHI, O .
JOURNAL OF BACTERIOLOGY, 1981, 145 (02) :814-823
[2]  
DEGENAAR CP, 1987, CLIN CHEM, V33, P1070
[3]   Increased fructose concentrations in blood and urine in patients with diabetes [J].
Kawasaki, T ;
Akanuma, H ;
Yamanouchi, TY .
DIABETES CARE, 2002, 25 (02) :353-357
[4]   FULLY ENZYMATIC INULIN DETERMINATION IN SMALL VOLUME SAMPLES WITHOUT DEPROTEINIZATION [J].
KUEHNLE, HF ;
SCHMIDT, FH ;
VONDAHL, K .
NEPHRON, 1992, 62 (01) :104-107
[5]   Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) [J].
Levey, AS ;
Eckardt, KU ;
Tsukamoto, Y ;
Levin, A ;
Coresh, J ;
Rossert, J ;
de Zeeuw, D ;
Hostetter, TH ;
Lameire, N ;
Eknoyan, G .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2089-2100
[6]  
Smith H., 1951, The Kidney: Structure and Function in Health and Disease, P231
[7]  
SOPER CPR, 1995, EUR J CLIN CHEM CLIN, V33, P497
[8]   A NEW ENZYMATIC METHOD FOR THE DETERMINATION OF INULIN [J].
SUGITA, O ;
TOMIYAMA, Y ;
MATSUTO, T ;
OKADA, M ;
GEJYO, F ;
ARAKAWA, M ;
TAKAHASHI, S ;
WATAZU, Y ;
KANEDA, N .
ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 :561-565
[9]  
SUMMERFIELD AL, 1993, CLIN CHEM, V39, P2333
[10]  
WHITE RP, 1954, J LAB CLIN MED, V43, P475